Basic Concepts on Laboratory Biosafety and Biosecurity Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

The origins of biosafety are rooted from?

A

US Biological weapons program

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

When did the US biological weapons program started?

A

1943

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Who ordered the US biological weapons program and when was it active?

A

US President Franklin Roosevelt, and it was active on Cold war

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Which president terminated the US biological weapon program and when was it?

A

US Pres. Richard Nixon in 1969

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

First scientific director of Camp Detrick and what year was it?

A

Ira L. Baldwin in 1943

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What was the purpose of Ira L. Baldwin the the Camp Detrick?

A

Task with establishing the biological weapons program for defensive purposes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the inherent component of biological Weapon Development

A

Biosafety

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Arnold Wedum contribution

A

Director of IHS (Industrial health and safety

also one of the pioneers in bio safety - developed practices and inventions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

-The first unofficial meeting at Camp Detrick (now Fort Detrick)
- Involved members of the military representing Camp Detrick, Pine Bluff Arsenal, Arkansas (PBA), and Dugway Proving Grounds, Utah (DPG).

A

April 18, 1955

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

The yearly meetings began to include non-classified sessions to broaden the reach of the Association

A

Beginning in 1957

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

1967

A

The height of increased mortality and morbidity due to smallpox– was eradicated by WHO

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

The attendees included universities, private laboratories, hospitals, and industry

A

1966 (this is connected with 1957)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

The impact of new OSHA regulations was analyzed and debated at the ASBA meeting;

A

1973

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

The CDC (Control of Disease Center) published the Classification of Etiological Agents on the Basis of Hazard.

A

1974

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

The NIH (National Institutes of Health) published the NIH Guidelines for Research Involving Recombinant DNA molecules.

A

1976

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Marked the development of the Laboratory Biosafety

A

-WHO’s first edition of the Laboratory Biosafety Manual (1983)
- CVC and NIH first edition of Biosafety in Microbiological and Biomedical Laboratories (1984)

17
Q

Becomes the code of practice for biosafety-the discipline addressing the safe handling and containment of infectious microorganisms and hazardous biological materials.

A

Biosafety in Microbiological and Biomedical Laboratories (1984) - CDC and NIH

18
Q

Ensures that safe handling and containment of infectious microorganisms and hazardous biological materials are being strictly followed and practiced in order to intervene the sequence of the chain of infection in the laboratory.

A

Biosafety in Microbiological and Biomedical Laboratories (1984) - CDC and NIH

19
Q

Containment principles, technologies, and practices implemented to prevent unintentional exposure to pathogens and toxins or their unintentional release

A

Laboratory Biosafety

20
Q

Traverse on how sources of pathogens are being managed and handled to prevent danger from arising, that could eventually affect people.

A

Laboratory Biosafety

21
Q

Protection, control and accountability for valuable biological materials within laboratories in order to prevent unauthorized access, loss, theft, misuse, diversion or intentional release.

A

Laboratory Biosecurity

22
Q

Shadows biosafety in terms of who are authorized to handle the pathogens, limit of access, and the intention of use and purpose.

A

Laboratory Biosecurity

23
Q

is protecting people from dangerous pathogens.

A

Biosafety

24
Q

is protecting pathogens from bad people.

A

Biosecurity

25
Q

★BASTA POST NI IDOL ⓛⓘⓚⓔ KO YAN.!!★ SANA LAGi KANG ACTiVE AH… para my #LiKE kana my #COMMENT kapa..😘😘❤♥❤😄😄 👇 👇 👇 👇 👇 👇 👇 BASTA WAG MONG KAKALIMUTAN MAG #LiKE_BACK AH.. 👉👉 💪👊 👈👈 👍👍😁😁😄😄 👇 👇 👇 👇 👇 👇 👇 👉👉 Sinu dito Gusto #ACTIVE_LiKER & #ACTiVE_COMMENTOR.?? #PM_muko para #ADD kita. #CF_TO_CF TAU.! 👍ⓛⓘⓚⓔ👍 ( BOY & GiRL ) #ACCEPTED…√√√ Ung #HONEST Lang na #TULAD_KO ah..😁😁✌👍 >ACTiVE AKO sa ACTiVE SAKiN< HONEST PA.! PROMiSE! ✋✋

A

haha idol labyu #jenopasakal

26
Q

Risk associated with biological materials.

A

Biorisk

27
Q

Includes microorganisms that are unlikely to cause human or animal disease. These microorganisms bring about low individual and community risk

A

Risk Group 1

28
Q

Microorganisms that are unlikely to be a significant risk to laboratory workers and the community, livestock, or the environment

May get infected but effective treatment and preventive measures are available

Moderate Risk to individual and limited community risk

A

Risk Group 2

29
Q

Microorganisms are known to cause serious diseases in humans or animals and may present significant risks to laboratory workers.

Serious or lethal human diseases for which preventive or therapeutic interventions may be available

High individual risk but low community risk

A

Risk Group 3

30
Q

Microorganisms are known to produce life-threatening diseases in humans or animals. Represents a significant risk to laboratory workers and may be readily transmissible from one individual to another

Serious or Lethal human diseases for which preventive or therapeutic interventions are not usually available.

High individual and community risk

A

Risk Group 4

31
Q

Not known to consistently cause disease in healthy adults

Standard Microbiological Practices

A

Biosafety Level 1 - BSL 1

32
Q

Laboratories that deal with indigenous moderate-risk agents

Agents associated with human disease

Routes of transmission include per- cutaneous injury, ingestion, mucous membrane exposure

A

Biosafety Level 2 - BSL 2

33
Q

Indigenous or exotic agents that may cause serious or potentially lethal diseases through the inhalation route of exposure

Puts emphasis on primary and secondary barriers in the protection

A

Biosafety Level 3 - BSL 3

34
Q

Dangerous/exotic agents which pose high risk of life-threatening disease, aerosol-transmitted lab infections; or related agents with unknown risk of transmission

A

Biosafety Level 4 - BSL 4